Zobrazeno 1 - 9
of 9
pro vyhledávání: '"Ulrike Sent"'
Autor:
Don Lorenzo Constantin Roventa, Ursula Pieper-Fürst, Cengizhan Acikel, Dunia Santos, Ulrike Sent, Ralph Mösges
Publikováno v:
Journal of Clinical Medicine, Vol 12, Iss 18, p 5813 (2023)
Acute pharyngitis can cause sore throat. This multicentre, active-controlled, randomised, open-label, and parallel-group study, conducted according to the German Medical Devices Act, compared the effectiveness and tolerability of ERS09 mouth and thro
Externí odkaz:
https://doaj.org/article/8a2ba178616d435fadb90c9e674863e2
Publikováno v:
Pulmonary Therapy, Vol 6, Iss 1, Pp 119-130 (2020)
Plain Language Summary Ambroxol is used to relieve the symptoms of respiratory conditions in which abnormal mucus secretion is a problem, including the common cold, acute and chronic bronchitis, and chronic obstructive pulmonary disease. Different fo
Externí odkaz:
https://doaj.org/article/590283d03b6a48cb9e4fbf4b976d145c
Publikováno v:
PLoS ONE, Vol 16, Iss 8 (2021)
Objective To explore the awareness and knowledge of applicable guidelines on acute cough among general practitioners, pharmacists and pharmacy technicians and to compare their recommendation behavior and clinical decision making to the evidence-based
Externí odkaz:
https://doaj.org/article/9878e773618a4a84a3fcdc3adb008f6d
Autor:
Peter Kardos, Kai-Michael Beeh, Ulrike Sent, Tobias Mueck, Heidemarie Gräter, Martin C. Michel
Publikováno v:
BMC Pharmacology and Toxicology, Vol 19, Iss 1, Pp 1-11 (2018)
Abstract Background Ambroxol relieves cough symptoms based on its secretagogue, anti-inflammatory, anti-oxidant, anti-bacterial, anti-viral, immunomodulatory and local anesthetic effects. The present study was designed to explore differential patient
Externí odkaz:
https://doaj.org/article/7912182e074b45ef8a213cf72da944fd
Publikováno v:
Pulmonary Therapy
Pulmonary Therapy, Vol 6, Iss 1, Pp 119-130 (2020)
Pulmonary Therapy, Vol 6, Iss 1, Pp 119-130 (2020)
Introduction Ambroxol is used in the treatment of acute and chronic respiratory conditions characterized by abnormal mucus secretion and impaired mucus transport and is available in a variety of formulations. This study aimed to compare the steady-st
Publikováno v:
PLoS ONE, Vol 16, Iss 8 (2021)
PLoS ONE
PLoS ONE, Vol 16, Iss 8, p e0254086 (2021)
PLoS ONE
PLoS ONE, Vol 16, Iss 8, p e0254086 (2021)
Objective To explore the awareness and knowledge of applicable guidelines on acute cough among general practitioners, pharmacists and pharmacy technicians and to compare their recommendation behavior and clinical decision making to the evidence-based
Publikováno v:
Multidisciplinary Respiratory Medicine. 15
Ambroxol (2-amino-3,5-dibromo-N-[trans-4-hydroxycyclohexyl]benzylamine), an over-thecounter product, is a mucoactive agent and has been used widely to treat both acute and chronic respiratory diseases since 1978. This review aims to provide an overvi
Autor:
Ulrike Sent, Kai-Michael Beeh, Heidemarie Gräter, Peter Kardos, Tobias Mueck, Martin C. Michel
Publikováno v:
BMC Pharmacology and Toxicology, Vol 19, Iss 1, Pp 1-11 (2018)
BMC Pharmacology & Toxicology
BMC Pharmacology & Toxicology
Background Ambroxol relieves cough symptoms based on its secretagogue, anti-inflammatory, anti-oxidant, anti-bacterial, anti-viral, immunomodulatory and local anesthetic effects. The present study was designed to explore differential patient profiles
Publikováno v:
Airway Pharmacology and Treatment.